Follow
Patrik Nikolić
Patrik Nikolić
Business Development Manager at Optibrium
Verified email at biorxpartners.com
Title
Cited by
Cited by
Year
In silico design of the first DNA-independent mechanism-based inhibitor of mammalian DNA methyltransferase Dnmt1
V Miletić, I Odorčić, P Nikolić, ŽM Svedružić
PloS one 12 (4), e0174410, 2017
242017
In Silico Optimization of the First DNA-Independent Mechanism-Based Inhibitor of Mammalian DNA Methyltransferase DNMT1
P Nikolić, V Miletić, I Odorcić, ŽM Svedružić
Epi-Informatics, 113-153, 2016
22016
Structure-Based Molecular Docking in the Identification of Novel Inhibitors Targeting SARS-CoV-2 Main Protease
V Miletić, P Nikolić, D Kinkela
2021 44th International Convention on Information, Communication and …, 2021
12021
DNA methyltransferase Dnmt1: Regulation and novel drug-design strategies
ZM Svedruzic, P Nikolic
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 248, 2014
2014
SUPERCOMPUTERS AS MICROSCOPES FOR THE 21ST CENTURY: SUBSTRATE CHANNELING, EPIGENETIC REGULATION, AND MOLECULAR BASIS OF ALZHEIMERS DISEASE
R Koren, M Martinović, P Nikolić, I Odorčić, L Ostojić, D Visentin, ...
BOOK OF ABSTRACTS, 54, 0
The system can't perform the operation now. Try again later.
Articles 1–5